Tarsier Pharma
IPOTarsier Pharma is a biotech company in Zichron Yaacov, Israel, founded in 2016. It has raised $2.6M across 3 rounds, most recently a $1.6M SAFE in July 2022.
Changing Lives by Saving Sight
- Headquarters
- Zichron Yaacov
- Founded
- 2016
- Website
- tarsierpharma.com
- Total Funding
- $2.6M
- Last Round
- $1.6M SAFEJul 2022
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds for this company. The full record is or through the API.
About
Tarsier Pharma is a late clinical-stage company developing bio-inspired treatments for autoimmune and inflammatory ocular diseases. Its patented Dazdotuftide platform uses a proprietary molecule intended to re-engineer immune-system activity and control inflammatory disease. The pipeline includes eye-drop and intravitreal-injection routes, with TRS01 in clinical development for non-infectious anterior uveitis, including uveitic glaucoma, and a broader focus on protecting patients from vision loss and blindness.
Summary
It has raised $2.6M in total across 3 rounds, most recently a $1.6M SAFE round in Jul 2022.
Funding & Exit History
Jul 2026
Sign up to see all 4 events
Funding: SAFE. Amounts, valuations, and investors where available.
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tarsier-pharma"><img src="https://indexed.vc/api/badge/company/tarsier-pharma" alt="Tarsier Pharma on Indexed.vc" width="260" height="76" /></a>